Rallybio Corporation
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
5.31M
on 2026-06-30, from 4.73M on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-8 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
S-3 of 2024-05-10. Not read yet. S-3 ↗
$9.6M
TD Securities (USA), agreement of 2022-08-15. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-06 is not read yet.
Cash
$92.8M
Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-06-01 | Private placement | not read | not read | $215.0M | 8-K ↗ |
| 2026-03-02 | Private placement | not read | not read | $505.5M | 8-K ↗ |
Also on file: a 1-for-5 reverse split, 2026-01-26 8-K ↗